Downregulation of CDK6 leads to inhibition of pancreatic cancer cell metastatic capacity, whereas increased CDK6 expression was observed in pancreatic cancer clinical samples and was associated with poor prognosis (27). The gene discussed is CDK6; the disease is pancreatic neoplasm.